Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 8Menorrhagia 2Leiomyoma 2Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

telapristone acetate 10ulipristal 3asoprisnil 3vilaprisan 2estradiol, norethindrone drug combination 2elagolix 2Norethindrone Acetate 2Mifepristone 2Lidocaine 2Leuprolide 2Estradiol 2ulipristal acetate 1relugolix 1pirfenidone 1epigallocatechin gallate 1Tea 1Sugars 1Simvastatin 1Ropivacaine 1Progesterone 1Morphine 1Methadone 1Injections, Subcutaneous 1Embolization, Therapeutic 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Leiomyoma × Estradiol × Clear all
NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed
271 enrolled 38 charts

Leiomyoma, Menorrhagia

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

AbbVie

Phase 2 Completed
571 enrolled 32 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡